Nexien BioPharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$239,113 over the previous period. Total operating expenses were $155,663.
Profit Margin
| 2015 | 0 | -48.44K | |
|---|---|---|---|
| 2016 | 0 | -20.98K | |
| 2017 | 0 | -258.65K | |
| 2018 | 0 | -1.28M | |
| 2019 | 0 | -5.03M | |
| 2020 | 0 | -2.67M | |
| 2021 | 0 | -1.87M | |
| 2022 | 0 | -626.35K | |
| 2023 | 0 | -361.90K | |
| 2024 | 0 | -239.11K |
NXEN Income Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 0 | 0 | 0 | 0 | 0 | 63.85K | 116.79K | 73.45K | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 155.66K | 282.60K | 563.99K | 1.84M | 2.63M | 3.93M | 1.28M | 258.65K | 20.98K | 48.44K |
Operating income | -155.66K | -282.60K | -563.99K | -1.84M | -2.63M | -3.56M | -1.28M | -258.65K | -20.98K | -48.44K |
Other income (expenses), net | -83.45K | -79.29K | -62.36K | -16.17K | -35.03K | -735.83K | 0 | -507.07K | 0 | -1.76K |
Income before tax | -239.11K | -361.90K | -626.35K | -1.85M | -2.67M | -4.30M | -1.28M | -258.65K | -20.98K | -48.44K |
Income tax expense | -239.11K | -282 | -563 | 16.17K | 33 | 735.83K | 0 | -765.73K | 0 | 0 |
Net income | -239.11K | -361.90K | -626.35K | -1.87M | -2.67M | -5.03M | -1.28M | -258.65K | -20.98K | -48.44K |
Earnings per share | ||||||||||
Basic EPS | -0.00 | -0.00 | -0.01 | -0.03 | -0.04 | -0.09 | -0.03 | -0.01 | -0.00 | -0.00 |
Diluted EPS | -0.00 | -0.00 | -0.01 | -0.03 | -0.04 | -0.09 | -0.03 | -0.01 | -0.00 | -0.00 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |